Latest News for: cutaneous conditions

Edit

Actinic Keratosis Market Forecast 2034: EMA, PDMA, FDA Approvals, Prevalence, Clinical Trials, Treatment, Medication, Therapies, ...

GetNews 07 Mar 2025
The hexokinase 2 inhibitor is being studied for its potential in treating advanced cases of actinic keratosis, a skin condition that may progress to cutaneous squamous cell carcinoma (SCC).
Edit

Micreos Pharmaceuticals Partners With Biologics CDMO Northway Biotech for Its Engineered Endolysin Therapeutic Manufacturing Program

ACCESSWIRE 04 Mar 2025
By developing targeted medicines that address the underlying pathophysiology associated with disease aggravation in conditions such as atopic dermatitis and cutaneous T-Cell lymphoma, and by ...
  • 1
×